Evonetix
Cambridge, United Kingdom · $66.3M raised
- Headquarters
- Cambridge
- Employees
- 51–200
- Business Model
- B2B
- Website
- evonetix.com
- Total Funding
- $66.3M
- Last Round
- $24.0M Extension RoundFeb 2023
- Rounds
- 3
About
Cambridge-based company developing a desktop DNA synthesis platform using a radically different approach to gene synthesis.
Summary
Evonetix is a Biotech company based in Cambridge, United Kingdom. It has raised $66.3M in total across 3 rounds, most recently a $24.0M Extension Round round in Feb 2023. Investors include Foresite Capital, Molten Ventures and DCVC (Data Collab).
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.